Genomic Assay Changes Minds on HER2+ Breast Cancer Treatment
The results from a prognostic genomic assay called HER2DX convinced a group of Spanish oncologists to change treatment plans for ...
The results from a prognostic genomic assay called HER2DX convinced a group of Spanish oncologists to change treatment plans for ...
A low-cost intervention that involved mailing patients an educational, personally tailored DVD along with follow-up telephone counseling significantly improved rates ...
Some patients with HER2-positive breast cancer can reduce the intensity of adjuvant chemotherapy while maintaining the full benefits in terms ...
NEW ORLEANS – Atorvastatin treatment of patients with lymphoma undergoing treatment with an anthracycline significantly cut the incidence of incident cardiac ...
Among the Hispanic/Latino population, the reported mortality rate of gastric cancer is low to moderate. In 2017, with regard to ...
When treating early-stage breast cancer, decisions made on age alone can miss the mark, say researchers reporting new data showing ...
The US Food and Drug Administration approved elacestrant (Orserdu, Stemline Therapeutics, Inc) for postmenopausal women or men with ER-positive, HER2-negative, ...
Tiny molecules of microribonucleic acids (miRNAs) found in breast milk can help protect babies from developing allergic conditions like atopic ...
© Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical News Hubb All rights reserved.